Vanesa Sanchez-Guajardo
Affiliations: | 2008-2013 | Biomedicine | Aarhus University, Aarhus, Denmark |
Google:
"Vanesa Sanchez-Guajardo"Mean distance: 16.49 (cluster 32) | S | N | B | C | P |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Elgueta D, Chovar O, Ugalde V, et al. (2022) Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein. Journal of Visualized Experiments : Jove |
| Olesen MN, Christiansen JR, Petersen SV, et al. (2018) CD4 T cells react to local increase of α-synuclein in a pathology-associated variant-dependent manner and modify brain microglia in absence of brain pathology. Heliyon. 4: e00513 |
| Kustrimovic N, Rasini E, Legnaro M, et al. (2016) Dopaminergic Receptors on CD4+ T Naive and Memory Lymphocytes Correlate with Motor Impairment in Patients with Parkinson's Disease. Scientific Reports. 6: 33738 |
| Christiansen JR, Olesen MN, Otzen DE, et al. (2016) α-Synuclein vaccination modulates regulatory T cell activation and microglia in the absence of brain pathology. Journal of Neuroinflammation. 13: 74 |
| Sanchez-Guajardo V, Tentillier N, Romero-Ramos M. (2015) The relation between α-synuclein and microglia in Parkinson's disease: Recent developments. Neuroscience |
| Romero-Ramos M, von Euler Chelpin M, Sanchez-Guajardo V. (2014) Vaccination strategies for Parkinson disease: induction of a swift attack or raising tolerance? Human Vaccines & Immunotherapeutics. 10: 852-67 |
| Chelpin MVE, Romero-ramos M, Sanchez-guajardo V. (2014) Neuroprotective role of Regulatory T cells in Parkinson's disease: Effect of COP-1/alpha-synuclein vaccination on pathology progression Journal of Neuroimmunology. 275: 210 |
| Romero-ramos M, Christiansen J, Sanchez-guajardo V. (2014) Alpha-synuclein immunization, in the absence of alpha-synuclein over-expression or neural pathology, modifies microglia activation patterns and T cells' activation profiles Journal of Neuroimmunology. 275: 208-209 |
| Sanchez-Guajardo V, Annibali A, Jensen PH, et al. (2013) α-Synuclein vaccination prevents the accumulation of parkinson disease-like pathologic inclusions in striatum in association with regulatory T cell recruitment in a rat model. Journal of Neuropathology and Experimental Neurology. 72: 624-45 |
| Febbraro F, Andersen KJ, Sanchez-Guajardo V, et al. (2013) Chronic intranasal deferoxamine ameliorates motor defects and pathology in the α-synuclein rAAV Parkinson's model. Experimental Neurology. 247: 45-58 |